phrykt

Eli Lilly (LLY) net income: $20.6B

Eli Lilly reported a net income of $20.6B for the year ended Dec 31, 2025, up 94.9% from $10.6B a year earlier.

From Eli Lilly's filings with the SEC · Read the filing · LLY stock page

Eli Lilly net income by year

$5.6B2021$6.2B2022$5.2B2023$10.6B2024$20.6B2025

#15 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025$20.6B+95%
Dec 31, 2024$10.6B+102%
Dec 31, 2023$5.2B-16%
Dec 31, 2022$6.2B+12%
Dec 31, 2021$5.6B–

Net income of similar companies

Companies in the same industry as Eli Lilly, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
Johnson & Johnson$26.8BDec 28, 2025
Eli Lilly$20.6BDec 31, 2025
Merck$18.3BDec 31, 2025
Pfizer$7.8BDec 31, 2025
Bristol Myers Squibb$7.1BDec 31, 2025
Abbott Laboratories$6.5BDec 31, 2025
Regeneron Pharmaceuticals$4.5BDec 31, 2025

Questions and answers

What is Eli Lilly's net income?

Eli Lilly reported a net income of $20.6B for the year ended Dec 31, 2025, up 94.9% from $10.6B a year earlier.

Numbers as reported in Eli Lilly's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology